000930.SZ
COFCO Biotechnology Co., Ltd.
SZSE · Basic Materials · C 制造业 · CN
CNY 4.70
−1.67%Year over year
Reported trailing growth
- Revenue
- -13.7%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- -48.2%
- Operating cash flow
- -10.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -4.2%
- EBITDA
- -34.5%
- EBIT
- —
- Net income
- -66.9%
- EPS
- -66.9%
- Free cash flow
- +101.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026